Aspirin, iron loss, and age-related macular degeneration

Medical Hypotheses

Volumn 74, Issue 4, 2010, Pages 754-755

  Mascitelli, Luca ^a   Pezzetta, Francesca ^b   Goldstein, Mark R ^c  

^a Comando Brigata Alpina Julia ^*  (Italy)

^b Ospedale Civile di Tolmezzo   (Italy)

^c Fountain Medical Court ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DEFEROXAMINE; FERRITIN; IRON; PLACEBO; PROTON PUMP INHIBITOR;

CLINICAL TRIAL; EYE PROTECTION; FERRITIN BLOOD LEVEL; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HUMAN; INCIDENCE; IRON CHELATION; IRON OVERLOAD; IRON STORAGE; LETTER; LOW DRUG DOSE; NONHUMAN; PATHOGENESIS; PHLEBOTOMY; PRIMARY PREVENTION; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; RISK REDUCTION;

ASPIRIN; GASTROINTESTINAL HEMORRHAGE; HUMANS; IRON OVERLOAD; MACULAR DEGENERATION;

EID: 77949266005     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.11.009     Document Type: Letter

References (12)

1. Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122 (2004) 564-572
2. Holz F.G., Pauleikhoff D., Klein R., and Bird A.C. Pathogenesis of lesions in late age-related macular disease. Am J Ophthalmol 137 (2004) 504-510
3. Wong R.W., Richa D.C., Hahn P., Green W.R., and Dunaief J.L. Iron toxicity as a potential factor in AMD. Retina 27 (2007) 997-1003
4. Hahn P., Milam A.H., and Dunaief J.L. Maculas affected by age-related macular degeneration contain increased chelatable iron in the retinal pigment epithelium and Bruch's membrane. Arch Ophthalmol 121 (2003) 1099-1105
5. Sullivan J.L. Is stored iron safe?. J Lab Clin Med 144 (2004) 280-284
6. Li Z.L., Lam S., and Tso M.O. Desferrioxamine ameliorates retinal photic injury in albino rats. Curr Eye Res 10 (1991) 133-144
7. Christen WG, Glynn RJ, Chew EY, Buring JE. Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women. Ophthalmology 2009 October 6 [Epub ahead of print].
8. Mascitelli L, Pezzetta F, Sullivan JL. Aspirin-associated iron loss as an anticancer mechanism. Med Hypotheses 2009 August 17 [Epub ahead of print].
9. Fleming D.J., Jacques P.F., Massaro J.M., D'Agostino Sr. R.B., Wilson P.W., and Wood R.J. Aspirin intake and the use of serum ferritin as a measure of iron status. Am J Clin Nutr 74 2 (2001) 219-226
10. Milman N., Ovesen L., Byg K., and Graudal N. Iron status in Danes updated 1994. I: prevalence of iron deficiency and iron overload in 1332 men aged 40-70 years. Influence of blood donation, alcohol intake, and iron supplementation. Ann Hematol 78 9 (1999) 393-400
11. Liu J.M., Hankinson S.E., Stampfer M.J., Rifai N., Willett W.C., and Ma J. Body iron stores and their determinants in healthy postmenopausal US women. Am J Clin Nutr 78 6 (2003) 1160-1167
12. Ridker P.M., Cook N.R., Lee I.M., et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. New Engl J Med 352 (2005) 1293-1304